A clinical trial carried out in Mali and the United States of America has shown that a new Ebola vaccine developed under the auspices of the World Health Organisation has promises. The study report published in the Lancet Infectious Diseases Journal

says the vaccine protects people who are close to Ebola patients such as health workers and

relatives and thus can break the transmission chain and hence curtail the spread of the disease.

The study was conducted by the University of Maryland, United States of America.

Share post
  • Tweet

Related Posts

Ethiopia: Italy, UNAIDS to support Ethiopian Aids prevention efforts

LAGOS: Randle hospital attacked by hoodlums

Fasting diet ‘regenerates diabetic pancreas’

Health minister inaugurates statutory committee for National Health Act

Women with Endometriosis more likely to suffer miscarriage

No Comments

Leave a Comment